JILL RIDENS: Open Payments
NPI 1508565110 · ANAHEIM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515 in 12 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $515
Food & beverage: $515
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $293 |
| Neurocrine BioSciences, Inc. | 3 | $112 |
| E.R. Squibb & Sons, L.L.C. | 2 | $51 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
Products named: ABILIFY MAINTENA, REXULTI, INGREZZA, COBENFY, AUSTEDO XR, ABILIFY ASIMTUFII, INVEGA SUSTENNA, UZEDY.
Industry payments across CA — which companies pay providers there.
